Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes
about
Cloning and characterization of a specific receptor for mouse oncostatin MPhosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activationAIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodiesLeukemia inhibitory factor (LIF)Oncostatin M promotes excitotoxicity by inhibiting glutamate uptake in astrocytes: implications in HIV-associated neurotoxicityFetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family membersPhosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytesOncostatin M receptor β and cysteine/histidine-rich 1 are biomarkers of the response to erythropoietin in hemodialysis patients.Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptorSTAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinaseAdenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligandSignaling network of Oncostatin M pathway.Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytesDetection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules.Cytokine-dependent gp130 receptor subunit regulates human fetal pituitary adrenocorticotropin hormone and growth hormone secretionJAK1/STAT3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer.Definition and characterization of an inhibitor for interleukin-31.Developmental abnormalities in mice transgenic for bovine oncostatin M.Regulation of nuclear translocation of nuclear factor-kappaB relA: evidence for complex dynamics at the single-cell level.Oncostatin M, leukaemia-inhibitory factor and interleukin 6 trigger different effects on alpha1-proteinase inhibitor synthesis in human lung-derived epithelial cells.Molecular dissection of human interleukin-31-mediated signal transduction through site-directed mutagenesis.Oncostatin M decreases interleukin-1 β secretion by human synovial fibroblasts and attenuates an acute inflammatory reaction in vivo.Coupling between Myogenesis and Angiogenesis during Skeletal Muscle Regeneration Is Stimulated by Restorative Macrophages.OSM binds LIFR:JAKs;OSMR:JAKs
P2860
Q24522490-97AA6CDC-54DF-4621-A81E-AC8079D8EEF2Q24563149-25DAFBD5-ACFF-4D17-ABE5-EB51446C5D1FQ24678972-A6303F8F-D1B0-4DB3-BBAD-35DEBD913189Q28082576-1B742418-3F9C-4511-8497-F5C09A7AD1ECQ28396730-AB5A5AEF-20F5-450D-B711-7F0D3A42F896Q28508942-1CA8B898-7990-4652-840D-1210A3F593E4Q28542037-D4BAA883-0A34-4FE8-9B83-29DF8FE6F3ABQ28637388-E0EFE209-B457-42A3-A623-0B182B988B78Q33625452-A47E1673-C4E5-4B2B-A475-56430EC5DFB0Q33633115-333A8494-D7F0-4CBF-8663-FBDB60BAA53BQ34087183-CDA69C99-6564-4422-8746-330F644F1C69Q35748007-8165666C-7638-4BBE-8DF9-256A9EF42ED2Q36864673-76184284-57BB-4FA9-A051-654A829D3747Q37052050-D07B7054-9E31-455D-AF08-615203F94A0AQ37350393-FECC5FF6-5ADC-4077-B26F-D2B5CF04C1ABQ37369789-BC757F23-5C6D-429F-A511-FE2D7444E1AEQ37370023-69DA2E61-E5D9-458D-A404-1BAE56441102Q38669181-BD94AC72-37DF-4130-9DDF-F5AC190E55E9Q39723416-F3B96CFF-D0E0-4C31-ADC4-CFDACADCB947Q40016116-6326AE35-E9C3-432A-8AE7-C16CA1527093Q40701221-0613F0E0-423E-4E01-9A46-8C61D30E2EC2Q42159470-F784056C-FD9E-4A5D-9CD0-DFD9638E765CQ42240282-E57682D3-F9B6-4881-9ED3-C0DD7358B603Q42914271-8E1CC76E-71BE-431E-AD2D-5D66AC5790A7Q47378119-E4551EA6-A90D-4BBA-B339-57E3D1E68044Q50292707-0528AE22-D609-4978-BB73-C79996980BCD
P2860
Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@ast
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@en
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@nl
type
label
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@ast
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@en
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@nl
prefLabel
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@ast
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@en
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@nl
P2093
P3181
P1476
Oncostatin M and leukemia inhi ...... ally shared receptor complexes
@en
P2093
P304
P3181
P407
P577
1994-02-25T00:00:00Z